Cargando…
The optimal chemotherapeutic regimen in D2-resected locally advanced gastric cancer: a propensity score-matched analysis
Adjuvant chemotherapy using TS-1 or capecitabine plus oxaliplatin improves survival outcomes after radical gastrectomy, with both regimens showing similar efficacies. A total of 494 patients with stage II‒III gastric cancer who underwent curative D2 gastrectomy and received adjuvant chemotherapy fro...
Autores principales: | Hwang, Jun Eul, Ki, Myung Seo, Kim, Karham, Jung, Sung-Hoon, Shim, Hyun-Jeong, Bae, Woo-Kyun, Hwang, Eu-Chang, Hur, Young Hoe, Jeong, Oh, Ryu, Seong Yeob, Park, Young Kyu, Cho, Sang-Hee, Lee, Ju-Seog, Chung, Ik-Joo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630436/ https://www.ncbi.nlm.nih.gov/pubmed/29029536 http://dx.doi.org/10.18632/oncotarget.16301 |
Ejemplares similares
-
Class III β-tubulin is a predictive marker for taxane-based chemotherapy in recurrent and metastatic gastric cancer
por: Hwang, Jun-Eul, et al.
Publicado: (2013) -
Complete biologic response to taxane based chemotherapy confirmed by [(18)F]FDG PET/CT and surgery in a cancer of unknown primary site
por: Hwang, Jun-Eul, et al.
Publicado: (2012) -
Adverse prognostic impact of splenectomy on survival in gastric carcinoma patients: Regression and propensity score matching analysis of 1074 patients
por: Jeong, Oh, et al.
Publicado: (2018) -
First-line single-agent chemotherapy for patients with recurrent or metastatic gastric cancer with poor performance status
por: HWANG, JUN-EUL, et al.
Publicado: (2012) -
Imatinib induced severe skin reactions and neutropenia in a patient with gastrointestinal stromal tumor
por: Hwang, Jun-Eul, et al.
Publicado: (2010)